About Evgenis Pharma Private Limited
Data last updated:
Evgenis Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 August 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2020PTC344564. Its GSTIN is 27AAGCE0455N1ZE (Maharashtra).
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹20 Lakh. It is led by directors including Kishor Dattatray Deo and Anurag Bhoop Narayan Pathak.
Its last annual general meeting (AGM) was held on 24 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 43 Windermere 2/B Oshiwara Link Road Lokhandwala Andheri West, Mumbai, Maharashtra, India – 400053.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.43 Cr, a decline of 31% compared to the previous year. For the same year it recorded a net loss of ₹1.18 Lakh (net margin -0.8%) and EBITDA of ₹56,187 (EBITDA margin 0.4%). Revenue has grown at a compounded annual rate (CAGR) of 63% over three years.
The company has about 4 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Evgenis Pharma. The company has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in June 2021. Its 10 peer companies in the Pharma industry (Contract Research, Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Healers Bioscience Private Limited with revenue of ₹1.45 Cr.
For more details, the company can be reached via its website evgenispharma.com.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address43 Windermere 2/B Oshiwara Link Road Lokhandwala Andheri West, Mumbai, Maharashtra, India – 400053
- IndustryPharma, Drug Formulation & Development, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Evgenis Pharma Private Limited
The main business activities of Evgenis Pharma are professional, scientific and technical and trade. In detail, this covers other professional, scientific and technical activities and wholesale trading. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Evgenis Pharma Private Limited FY 2025 filings available
Evgenis Pharma Private Limited reported revenue of ₹1.43 Cr (down 31% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Evgenis Pharma Private Limited
Revenue fell 31% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 63%. EBITDA rose 859% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Evgenis Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹56,187 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.18 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Evgenis Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -0.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Evgenis Pharma are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Evgenis Pharma Private Limited
Evgenis Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research, Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Healers Bioscience Private Limited | ₹1.45 Cr (FY 2024) | •••• | •••• | 132.0% | •••• | Bangalore South, Karnataka, India |
| Relez Pharma Private Limited | ₹1.44 Cr (FY 2025) | •••• | •••• | 71.0% | •••• | Surat, Gujarat, India |
| Atrol Pharmaceuticals Private Limited | ₹1.44 Cr (FY 2025) | •••• | •••• | 935.0% | •••• | Bangalore South, Karnataka, India |
| Cytocare Formulations Private Limited | ₹1.44 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Kolkata, West Bengal, India |
| Catholicon Lifesciences Private Limited | ₹1.44 Cr (FY 2025) | •••• | •••• | 68.0% | •••• | Mumbai, Maharashtra, India |
| Evgenis Pharma Private Limited this company | ₹1.43 Cr (FY 2025) | •••• | •••• | -31.0% | •••• | Mumbai, Maharashtra, India |
| Cogniwell Pharmaceuticals Private Limited | ₹1.43 Cr (FY 2024) | •••• | •••• | -28.0% | •••• | Bangalore, Karnataka, India |
| KTM Healthcare Private Limited | ₹1.43 Cr (FY 2025) | •••• | •••• | -30.0% | •••• | Noida, Uttar Pradesh, India |
| Brunhild Pharmaceuticals Private Limited | ₹1.43 Cr (FY 2024) | •••• | •••• | 57.0% | •••• | Naigaon, Maharashtra, India |
| V.G.I Pharma Private Limited | ₹1.43 Cr (FY 2019) | •••• | •••• | -8.0% | •••• | Akola, Maharashtra, India |
| Excellamed Laboratories Private Limited | ₹1.43 Cr (FY 2025) | •••• | •••• | 47.0% | •••• | Kandivlai West, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Evgenis Pharma by revenue in the Pharma industry (Contract Research, Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Evgenis Pharma Private Limited
Evgenis Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kishor Dattatray Deo | Director | 19 Nov 2020 | 5 Years 10 Months | Current |
| Anurag Bhoop Narayan Pathak | Director | 26 Aug 2020 | 6 Years 1 Months | Current |
| Balwant Shankarrao Desai | Director | 26 Aug 2020 | 6 Years 1 Months | Current |
Charges & Borrowings of Evgenis Pharma Private Limited
Evgenis Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Evgenis Pharma Private Limited
Evgenis Pharma Private Limited has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in June 2021.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2021 | Rights issue | ₹17 Lakh | Investors: Omnicals Pharma Private Limited , 3 individuals |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Full deal history
All 2 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Associated Brands with Evgenis Pharma Private Limited
Evgenis Pharma operates one associated brand: Evgenis Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers pharmaceutical research, development, regulatory affairs, and commercialization support services. | evgenispharma.com |
Employees and EPFO Compliance at Evgenis Pharma Private Limited
Employment history and EPFO contributions of people linked to Evgenis Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Evgenis Pharma Private Limited
Evgenis Pharma Private Limited has 5 board changes on record since 2020: 3 appointments and 2 cessations. The latest: Kishor Dattatray Deo ceased to be Additional Director on 29 Sep 2021.
Credit Ratings, Litigation & Regulatory Alerts for Evgenis Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Evgenis Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Evgenis Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Evgenis Pharma Private Limited
Evgenis Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCE0455N1ZE | Maharashtra | Active | 21 Dec 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Evgenis Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Evgenis Pharma Private Limited
Evgenis Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 August 2020 (6+ years old) and is registered under CIN U74999MH2020PTC344564.
Evgenis Pharma reported revenue of ₹1.43 Cr for FY 2025 (down 31% YoY).
Evgenis Pharma has 3 current directors:
- Kishor Dattatray Deo - Director
- Anurag Bhoop Narayan Pathak - Director
- Balwant Shankarrao Desai - Director
Evgenis Pharma reported a net loss of ₹1.18 Lakh (net margin -0.8%) and EBITDA of ₹56,187 (EBITDA margin 0.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Evgenis Pharma is 63% over three years. In the latest year (FY 2025) revenue fell 31%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Evgenis Pharma is 27AAGCE0455N1ZE, registered in Maharashtra.
The CIN (Corporate Identification Number) of Evgenis Pharma is U74999MH2020PTC344564. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Evgenis Pharma was incorporated on 26 August 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
Evgenis Pharma has 2 deals on record (1 rights issue, 1 secondary share transfer); the latest was in June 2021.
The peers of Evgenis Pharma by revenue are Healers Bioscience Private Limited, Relez Pharma Private Limited, Atrol Pharmaceuticals Private Limited, Cytocare Formulations Private Limited, Catholicon Lifesciences Private Limited and 5 more, all in the Pharma industry (Contract Research, Formulations).
Kishor Dattatray Deo ceased to be Additional Director on 29 Sep 2021. Kishor Dattatray Deo was appointed as Director on 19 Nov 2020. Madhuri Kishor Deo ceased to be Director on 19 Nov 2020. Evgenis Pharma has 5 board changes on record in total.